OPKO Health (OPK) Reports Q2 Loss Per Share of 2c, Revenue Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.77 +2.91%
EPS Growth %: -333.3%
Financial Fact:
Operating loss: -23.62M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -333.3%
Financial Fact:
Operating loss: -23.62M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
OPKO Health (NYSE: OPK) reported Q1 EPS of ($0.02), may not compare to the analyst estimate of ($0.03). Revenue for the quarter came in at $291 million versus the consensus estimate of $266.3 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Datadog stock tumbles 19% despite earnings beat
- Stifel Positive on Rapport Therapeutics (RAPP): 'remains on track to share longer-term safety data from the ph2a in 4Q26'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
